Cargando…

Morphological Response in Cancer Spheroids for Screening Photodynamic Therapy Parameters

Photodynamic therapy (PDT) is a treatment which uses light-activated compounds to produce reactive oxygen species, leading to membrane damage and cell death. Multicellular cancer spheroids are a preferable alternative for PDT evaluation in comparison to monolayer cell cultures due to their ability t...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar Cosme, Jose R., Gagui, Dan C., Bryant, Helen E., Claeyssens, Frederik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637197/
https://www.ncbi.nlm.nih.gov/pubmed/34869604
http://dx.doi.org/10.3389/fmolb.2021.784962
_version_ 1784608694816735232
author Aguilar Cosme, Jose R.
Gagui, Dan C.
Bryant, Helen E.
Claeyssens, Frederik
author_facet Aguilar Cosme, Jose R.
Gagui, Dan C.
Bryant, Helen E.
Claeyssens, Frederik
author_sort Aguilar Cosme, Jose R.
collection PubMed
description Photodynamic therapy (PDT) is a treatment which uses light-activated compounds to produce reactive oxygen species, leading to membrane damage and cell death. Multicellular cancer spheroids are a preferable alternative for PDT evaluation in comparison to monolayer cell cultures due to their ability to better mimic in vivo avascular tumour characteristics such as hypoxia and cell-cell interactions, low cost, and ease of production. However, inconsistent growth kinetics and drug responsiveness causes poor experimental reproducibility and limits their usefulness. Herein, we used image analysis to establish a link between human melanoma C8161 spheroid morphology and drug responsiveness. Spheroids were pre-selected based on sphericity, area, and diameter, reducing variation in experimental groups before treatment. Spheroid morphology after PDT was analyzed using AnaSP and ReViSP, MATLAB-based open-source software, obtaining nine different parameters. Spheroids displayed a linear response between biological assays and morphology, with area (R(2) = 0.7219) and volume (R(2) = 0.6138) showing the best fit. Sphericity, convexity, and solidity were confirmed as poor standalone indicators of spheroid viability. Our results indicate spheroid morphometric parameters can be used to accurately screen inefficient treatment combinations of novel compounds.
format Online
Article
Text
id pubmed-8637197
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86371972021-12-03 Morphological Response in Cancer Spheroids for Screening Photodynamic Therapy Parameters Aguilar Cosme, Jose R. Gagui, Dan C. Bryant, Helen E. Claeyssens, Frederik Front Mol Biosci Molecular Biosciences Photodynamic therapy (PDT) is a treatment which uses light-activated compounds to produce reactive oxygen species, leading to membrane damage and cell death. Multicellular cancer spheroids are a preferable alternative for PDT evaluation in comparison to monolayer cell cultures due to their ability to better mimic in vivo avascular tumour characteristics such as hypoxia and cell-cell interactions, low cost, and ease of production. However, inconsistent growth kinetics and drug responsiveness causes poor experimental reproducibility and limits their usefulness. Herein, we used image analysis to establish a link between human melanoma C8161 spheroid morphology and drug responsiveness. Spheroids were pre-selected based on sphericity, area, and diameter, reducing variation in experimental groups before treatment. Spheroid morphology after PDT was analyzed using AnaSP and ReViSP, MATLAB-based open-source software, obtaining nine different parameters. Spheroids displayed a linear response between biological assays and morphology, with area (R(2) = 0.7219) and volume (R(2) = 0.6138) showing the best fit. Sphericity, convexity, and solidity were confirmed as poor standalone indicators of spheroid viability. Our results indicate spheroid morphometric parameters can be used to accurately screen inefficient treatment combinations of novel compounds. Frontiers Media S.A. 2021-11-18 /pmc/articles/PMC8637197/ /pubmed/34869604 http://dx.doi.org/10.3389/fmolb.2021.784962 Text en Copyright © 2021 Aguilar Cosme, Gagui, Bryant and Claeyssens. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Aguilar Cosme, Jose R.
Gagui, Dan C.
Bryant, Helen E.
Claeyssens, Frederik
Morphological Response in Cancer Spheroids for Screening Photodynamic Therapy Parameters
title Morphological Response in Cancer Spheroids for Screening Photodynamic Therapy Parameters
title_full Morphological Response in Cancer Spheroids for Screening Photodynamic Therapy Parameters
title_fullStr Morphological Response in Cancer Spheroids for Screening Photodynamic Therapy Parameters
title_full_unstemmed Morphological Response in Cancer Spheroids for Screening Photodynamic Therapy Parameters
title_short Morphological Response in Cancer Spheroids for Screening Photodynamic Therapy Parameters
title_sort morphological response in cancer spheroids for screening photodynamic therapy parameters
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637197/
https://www.ncbi.nlm.nih.gov/pubmed/34869604
http://dx.doi.org/10.3389/fmolb.2021.784962
work_keys_str_mv AT aguilarcosmejoser morphologicalresponseincancerspheroidsforscreeningphotodynamictherapyparameters
AT gaguidanc morphologicalresponseincancerspheroidsforscreeningphotodynamictherapyparameters
AT bryanthelene morphologicalresponseincancerspheroidsforscreeningphotodynamictherapyparameters
AT claeyssensfrederik morphologicalresponseincancerspheroidsforscreeningphotodynamictherapyparameters